461 related articles for article (PubMed ID: 36205914)
1. Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.
Chopra G; Shabir S; Yousuf S; Kauts S; Bhat SA; Mir AH; Singh MP
Mol Neurobiol; 2022 Dec; 59(12):7513-7540. PubMed ID: 36205914
[TBL] [Abstract][Full Text] [Related]
2. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.
Soto C; Pritzkow S
Nat Neurosci; 2018 Oct; 21(10):1332-1340. PubMed ID: 30250260
[TBL] [Abstract][Full Text] [Related]
3. Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases.
Bhat MA; Ahmad K; Khan MSA; Bhat MA; Almatroudi A; Rahman S; Jan AT
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32516961
[TBL] [Abstract][Full Text] [Related]
4. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
5. Protein misfolding and neurodegeneration.
Soto C; Estrada LD
Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
[TBL] [Abstract][Full Text] [Related]
6. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
7. Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology.
Yang H; Hu HY
FEBS J; 2016 Oct; 283(20):3705-3717. PubMed ID: 27016044
[TBL] [Abstract][Full Text] [Related]
8. Targeting small heat shock proteins to degrade aggregates as a potential strategy in neurodegenerative diseases.
Lei T; Xiao Z; Bi W; Cai S; Yang Y; Du H
Ageing Res Rev; 2022 Dec; 82():101769. PubMed ID: 36283618
[TBL] [Abstract][Full Text] [Related]
9. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
10. Cell-free amplification of prions: Where do we stand?
Cazzaniga FA; De Luca CMG; Bistaffa E; Consonni A; Legname G; Giaccone G; Moda F
Prog Mol Biol Transl Sci; 2020; 175():325-358. PubMed ID: 32958239
[TBL] [Abstract][Full Text] [Related]
11. Using reporters of different misfolded proteins reveals differential strategies in processing protein aggregates.
Schneider KL; Ahmadpour D; Keuenhof KS; Eisele-Bürger AM; Berglund LL; Eisele F; Babazadeh R; Höög JL; Nyström T; Widlund PO
J Biol Chem; 2022 Nov; 298(11):102476. PubMed ID: 36096201
[TBL] [Abstract][Full Text] [Related]
12. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
Arawaka S; Machiya Y; Kato T
Curr Pharm Biotechnol; 2010 Feb; 11(2):158-66. PubMed ID: 20170473
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.
Yoshida S; Hasegawa T
Neurochem Int; 2022 May; 155():105307. PubMed ID: 35181393
[TBL] [Abstract][Full Text] [Related]
14. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
15. Carnosol Reduced Pathogenic Protein Aggregation and Cognitive Impairment in Neurodegenerative Diseases Models via Improving Proteostasis and Ameliorating Mitochondrial Disorders.
Chen Y; Qin Q; Zhao W; Luo D; Huang Y; Liu G; Kuang Y; Cao Y; Chen Y
J Agric Food Chem; 2022 Aug; 70(34):10490-10505. PubMed ID: 35973126
[TBL] [Abstract][Full Text] [Related]
16. TRIM family proteins: roles in proteostasis and neurodegenerative diseases.
Zhu Y; Afolabi LO; Wan X; Shim JS; Chen L
Open Biol; 2022 Aug; 12(8):220098. PubMed ID: 35946309
[TBL] [Abstract][Full Text] [Related]
17. A mathematical model of the dynamics of prion aggregates with chaperone-mediated fragmentation.
Davis JK; Sindi SS
J Math Biol; 2016 May; 72(6):1555-78. PubMed ID: 26297259
[TBL] [Abstract][Full Text] [Related]
18. Lanosterol Suppresses the Aggregation and Cytotoxicity of Misfolded Proteins Linked with Neurodegenerative Diseases.
Upadhyay A; Amanullah A; Mishra R; Kumar A; Mishra A
Mol Neurobiol; 2018 Feb; 55(2):1169-1182. PubMed ID: 28102469
[TBL] [Abstract][Full Text] [Related]
19. Heat shock proteins: therapeutic drug targets for chronic neurodegeneration?
Sajjad MU; Samson B; Wyttenbach A
Curr Pharm Biotechnol; 2010 Feb; 11(2):198-215. PubMed ID: 20166961
[TBL] [Abstract][Full Text] [Related]
20. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
